India Weekly: Pharma threat, tariff-front running, China dumping

A US import levy on pharmaceuticals would be a blow to India’s economy but far from a fatal one: pharmaceuticals have been a longstanding strong-point in India's export sector but they have been overtaken by electronics in recent years.

Subscriber content

Read this in full, free

Start a free trial and use one of your 10 free starter credits to unlock this piece.


Free. 10 articles. No card required.
By completing this form you are agreeing to our Terms and Conditions for the provision of a free trial of Capital Economics' services. We take your privacy seriously and will not share your details with others without your consent. By providing your details, including your email address, you are consenting to Capital Economics sending you macroeconomic commentary and analysis. You can unsubscribe at any time. See our Privacy Policy for more information.

Already a client or trialist? Log in to read this.